Hardy DJ et al. |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview. |
1992 |
Diagn. Microbiol. Infect. Dis. |
pmid:1530914
|
Chu S et al. |
Drug-food interaction potential of clarithromycin, a new macrolide antimicrobial. |
1992 |
J Clin Pharmacol |
pmid:1531484
|
Guay DR and Craft JC |
Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. |
1992 |
J. Intern. Med. |
pmid:1532615
|
Ruf B et al. |
Failure of clarithromycin in preventing toxoplasmic encephalitis in AIDS patients. |
1992 |
J. Acquir. Immune Defic. Syndr. |
pmid:1532831
|
Brown BA et al. |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1317144
|
Chu SY et al. |
Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489187
|
Araujo FG et al. |
Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489188
|
Gan VN et al. |
Pharmacokinetics of a clarithromycin suspension in infants and children. |
1992 |
Antimicrob. Agents Chemother. |
pmid:1489191
|
Denny FW |
Current management of streptococcal pharyngitis. |
1992 |
J Fam Pract |
pmid:1453145
|
Chapelsky MC et al. |
Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers. |
1992 Jul-Aug |
Drug Saf |
pmid:1355971
|
Hoover WW et al. |
Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. |
1992 Mar-Apr |
Diagn. Microbiol. Infect. Dis. |
pmid:1533827
|
de Campora E et al. |
Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535578
|
Nilsen OG et al. |
Macrolide pharmacokinetics and dose scheduling of roxithromycin. |
1992 May-Jun |
Diagn. Microbiol. Infect. Dis. |
pmid:1535579
|
Friend DR |
Polyacrylate resin microcapsules for taste masking of antibiotics. |
1992 Oct-Dec |
J Microencapsul |
pmid:1403495
|
Ruf B et al. |
Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients. |
1992 Sep-Oct |
Infection |
pmid:1428183
|
Maurin M and Raoult D |
In vitro susceptibilities of spotted fever group rickettsiae and Coxiella burnetti to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8109928
|
Parish LC |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group. |
1993 |
Int. J. Dermatol. |
pmid:8340194
|
|
Clarithromycin effectively treats infection in AIDS patients. |
1993 |
Oncology (Williston Park, N.Y.) |
pmid:8512782
|
Clark JA and Margolis DM |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex. |
1993 |
Clin. Infect. Dis. |
pmid:8513064
|
Alba D et al. |
[Clarithromycin in the treatment of cerebral toxoplasmosis associated with HIV infection]. |
1993 |
Rev Clin Esp |
pmid:8516514
|
Calhoun KH and Hokanson JA |
Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis. |
1993 |
Arch Fam Med |
pmid:8111512
|
Saint-Marc T et al. |
[Mycobacterium avium intracellulare infections. Treatment with a clarithromycin-clofazimine combination. 18 cases]. |
1993 |
Presse Med |
pmid:8121903
|
Akiyama H et al. |
Interaction of Staphylococcus aureus cells and silk threads in vitro and in mouse skin. |
1993 |
J. Dermatol. Sci. |
pmid:8136322
|
Granier H et al. |
[Mycobacterium chelonei arthritis in an immunosuppressed patient. Efficacy of the treatment with clarithromycin]. |
1993 |
Ann Med Interne (Paris) |
pmid:8141516
|
MacGowan AR et al. |
Synergy testing of macrolide combinations using the chequerboard technique. |
1993 |
J. Antimicrob. Chemother. |
pmid:8144439
|
Ximenes E et al. |
[Ciprofloxacin, clarithromycin, rifampin: in vitro bactericidal activity of double and triple drug combinations against strains of atypical mycobacteria]. |
1993 |
Pathol. Biol. |
pmid:8233629
|
Peterson WL et al. |
Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. |
1993 |
Am. J. Gastroenterol. |
pmid:8237933
|
Romand S et al. |
In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285620
|
Schmidt T et al. |
Clarithromycin lacks bactericidal activity in cerebrospinal fluid in experimental pneumococcal meningitis. |
1993 |
J. Antimicrob. Chemother. |
pmid:8288505
|
Walker LL et al. |
Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin. |
1993 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:8326182
|
Alder J et al. |
Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328782
|
Mor N and Heifets L |
Inhibition of intracellular growth of Mycobacterium avium by one pulsed exposure of infected macrophages to clarithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8328792
|
Chien SM et al. |
Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin with erythromycin. Canada-Sweden Clarithromycin-Pneumonia Study Group. |
1993 |
Chest |
pmid:8449054
|
Watanabe Y et al. |
Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin. |
1993 |
J. Antibiot. |
pmid:8501007
|
Roig J et al. |
Treatment of Legionnaires' disease. Current recommendations. |
1993 |
Drugs |
pmid:7691508
|
Still JG et al. |
Comparison of clarithromycin and penicillin VK suspensions in the treatment of children with streptococcal pharyngitis and review of currently available alternative antibiotic therapies. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295815
|
Craft JC and Siepman N |
Overview of the safety profile of clarithromycin suspension in pediatric patients. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295816
|
Klein JO |
Clarithromycin: where do we go from here? |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295817
|
Hardy DJ |
Extent and spectrum of the antimicrobial activity of clarithromycin. |
1993 |
Pediatr. Infect. Dis. J. |
pmid:8295818
|
Dubois J et al. |
Efficacy of clarithromycin vs. amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. |
1993 |
Ear Nose Throat J |
pmid:8313865
|
Nasu M |
[Helicobacter pylori infections]. |
1993 |
Nippon Naika Gakkai Zasshi |
pmid:8315343
|
Braga PC and Piatti G |
Sub-lethal concentrations of clarithromycin interfere with the expression of Staphylococcus aureus adhesiveness to human cells. |
1993 |
J Chemother |
pmid:8371124
|
Lonks JR and Medeiros AA |
High rate of erythromycin and clarithromycin resistance among Streptococcus pneumoniae isolates from blood cultures from Providence, R.I. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239578
|
Klopman G et al. |
Anti-Mycobacterium avium activity of quinolones: in vitro activities. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8239587
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Goldstein EJ and Citron DM |
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390810
|
Watanabe Y et al. |
Chemical modification of erythromycins. XII. A facile synthesis of clarithromycin (6-O-methylerythromycin A) via 2'-silylethers of erythromycin A derivatives. |
1993 |
J. Antibiot. |
pmid:8360112
|